Contract drug developer Pharmaceutical Product Development Inc. said Tuesday that its first-quarter net income surged on a boost in revenue from clinical development services.
PPD earned $37.6 million, or 32 cents per share, up from profit of $17.2 million, or 14 cents per share, during the same period a year prior. Revenue rose nearly 11 percent to $383.2 million from $346.8 million.
Analysts polled by FactSet had expected 33 cents per share in profit on $361.9 million in revenue.
In January, the company set guidance for 2011. It expects to earn between $1.53 and $1.69 per share in 2011 on revenue of $1.48 billion to $1.58 billion. Analysts have forecast full-year profit of $1.62 per share on $1.53 billion in revenue.
Regards,
Don
More on this topic
(What's this?)
Pharmaceutical Product Development Rallies On Buyout Rumor
(Stock Wizard, 7/18/11)
(PPDI) Pharmaceutical Product Development to Go Private
(Stock Blog Hub, 10/11/11)
Pre-Paid Legal Services Jumps on P-E Rumors (PPD)
(Benzinga, 10/25/10)
Pre-Paid Legal Jumping In Pre-Market On Offer (PPD)
(Benzinga, 10/25/10)

![[del.icio.us]](http://pennystockdd.com/wp-content/plugins/bookmarkify/delicious.png)
![[Digg]](http://pennystockdd.com/wp-content/plugins/bookmarkify/digg.png)
![[Faves]](http://pennystockdd.com/wp-content/plugins/bookmarkify/faves.png)
![[LinkedIn]](http://pennystockdd.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Reddit]](http://pennystockdd.com/wp-content/plugins/bookmarkify/reddit.png)
![[StumbleUpon]](http://pennystockdd.com/wp-content/plugins/bookmarkify/stumbleupon.png)
![[Technorati]](http://pennystockdd.com/wp-content/plugins/bookmarkify/technorati.png)




